Therapeutic Bed Market Size, Share & Trends Analysis Report By Product (Clinical, Household Beds), By Application (Acute Care, Critical Care Beds), By End Use, By Region, And Segment Forecasts, 2022 - 2030

April 2022 | 158 pages | ID: T0BA72F3762EN
Grand View Research, Inc.

Abstracts

This report can be delivered to the clients within Immediate

Therapeutic Bed Market Growth & Trends

The global therapeutic bed market size is anticipated to reach USD 6.51 billion by 2030, registering a CAGR of 5.01% during the forecast period, according to a new report by Grand View Research, Inc. The increasing prevalence of chronic disorders, such as cancer, heart disorders, neurological disorders, kidney disorders, and others, and the growing geriatric population are the key driving factors for the market. According to the WHO, in 2020, the chronic illness prevalence increased by 57%, which is anticipated to spur market growth in the near future. The COVID-19 outbreak in 2020 increased the demand for therapeutic beds significantly.

The pandemic has boosted the demand for emergency supplies, medicines, and medical equipment, such as ventilators, and hospital beds, as a result of increased hospital admissions. In addition, firms are also adopting several strategies, such as collaborations and new product launches, to help healthcare workers. For instance, in August 2020, Project C.U.R.E. received 22,500 Emergency Relief Bed (ERB) sets from Stryker. A mattress, IV pole, and bed frame were included in the ERB kits. As a result, the market is likely to grow substantially in the near future.

Furthermore, pressure injuries are a common and significant economic challenge for healthcare systems globally, costing the U.S. healthcare system more than USD 23.50 billion each year. Various manufacturers began offering solutions, such as special beds, therapeutic mattresses, and repositioning solutions, to reduce the burden of pressure injuries. Moreover, after the onset of the COVID-19 pandemic, there has been extensive demand for pressure relief beds & mattresses in hospitals and rehabilitation centers. These factors are expected to boost the market growth over the forecast period.

Therapeutic Bed Market Report Highlights

• The clinical beds' product segment dominated the global market in 2021 and accounted for the largest revenue share
• High ICU admission rates owing to a rise in the number of accidents, growth in the geriatric population, and outbreaks of life-threatening infectious diseases are driving the segment
• The acute care beds application segment led the global market in 2021 accounting for the largest revenue
• This growth was attributed to multifunctional applications, such as managing labor (maternity), providing treatment to the injury, reducing the severity of mental illness, and protecting against exacerbation or complications
• The market in Europe held a substantial revenue share in 2021 owing to a rise in the number of surgical procedures, high geriatric population, and favorable reimbursement policies in the region

Contents

CHAPTER 1 METHODOLOGY AND SCOPE

1.1 Market Segmentation & Scope
  1.1.1 Product
  1.1.2 Application
  1.1.3 End-use
  1.1.4 Regional Scope
  1.1.5 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
  1.3.1 Purchased Database
  1.3.2 Gvr’s Internal Database
  1.3.3 Secondary Sources
  1.3.4 Primary Research
  1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
  1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
  1.6.1 Commodity Flow Analysis (Model 1)
  1.6.2 Volume Price Analysis (Model 2)
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
  1.10.1 Objective - 1:
  1.10.2 Objective - 2:
  1.10.3 Objective - 3:
  1.10.4 Objective - 4:

CHAPTER 2 EXECUTIVE SUMMARY

2.1 Market Outlook

CHAPTER 3 THERAPEUTIC BEDS MARKET: VARIABLES, TRENDS, & SCOPE

3.1 Market Segmentation and Scope
3.2 Market Driver Analysis
  3.2.1 Increasing prevalence of chronic diseases requiring long-term care
  3.2.2 Growing demand for home healthcare
  3.2.3 Improvements in public and private hospital infrastructure
  3.2.4 Growing geriatric population
3.3 Market Restraint Analysis
  3.3.1 High cost of therapeutic beds
  3.3.2 Limited availability of technology and funds preventing indigenous manufacturing in emerging economies
3.4 Market Opportunities Analysis
  3.4.1 Technological advancements by manufacturers
  3.4.2 Increasing launch of delivery beds IS expected to drive growth of the global therapeutic bed market
3.5 Penetration & Growth Prospect Mapping
3.6 Porter’s Five Forces Analysis
3.7 PESTEL Analysis
3.8 Impact of COVID-19 & Post-COVID Recovery Analysis

CHAPTER 4 THERAPEUTIC BEDS MARKET: PRODUCT SEGMENT ANALYSIS, 2017 - 2030 (USD MILLION)

4.1 Definition and Scope
4.2 Product Market Share Analysis, 2021 & 2030
4.3 Segment Dashboard
4.4 Global Therapeutic Beds Market, by Product, 2017 to 2030
4.5 Market Size & Forecasts and Trend Analyses, 2017 to 2030
  4.5.1 CLINICAL BEDS
    4.5.1.1 Clinical beds market, 2017 - 2030 (USD Million)
    4.5.1.2 Regular beds market, 2017 - 2030 (USD Million)
    4.5.1.3 ICU beds market, 2017 - 2030 (USD Million)
    4.5.1.4 Pediatric beds market, 2017 - 2030 (USD Million)
    4.5.1.5 Birthing beds market, 2017 - 2030 (USD Million)
    4.5.1.6 Bariatric beds market, 2017 - 2030 (USD Million)
    4.5.1.7 Low air loss beds beds market, 2017 - 2030 (USD Million)
    4.5.1.8 Others market, 2017 - 2030 (USD Million)
  4.5.2 HOUSEHOLD BEDS
    4.5.2.1 Household beds market, 2017 - 2030 (USD Million)
  4.5.3 ACCESSORIES
    4.5.3.1 Accessories market, 2017 - 2030 (USD Million)

CHAPTER 5 THERAPEUTIC BEDS MARKET: APPLICATION SEGMENT ANALYSIS, 2017 - 2030 (USD MILLION)

5.1 Definition and Scope
5.2 Application Market Share Analysis, 2021 & 2030
5.3 Segment Dashboard
5.4 Global Therapeutic Beds Market, by Application, 2017 to 2030
5.5 Market Size & Forecasts and Trend Analyses, 2017 to 2030
  5.6.1 ACUTE CARE BEDS
    5.6.1.1 Acute care beds market, 2017 - 2030 (USD Million)
  5.6.2 CRITICAL CARE BEDS
    5.6.2.1 Critical care beds market, 2017 - 2030 (USD Million)
  5.6.3 LONG-TERM BEDS
    5.6.3.1 Long-term beds market, 2017 - 2030 (USD Million)

CHAPTER 6 THERAPEUTIC BEDS MARKET: END-USE SEGMENT ANALYSIS, 2017 - 2030 (USD MILLION)

6.1 Definition and Scope
6.2 End-use Market Share Analysis, 2021 & 2030
6.3 Segment Dashboard
6.4 Global Therapeutic Beds Market, by End-use, 2017 to 2030
6.5 Market Size & Forecasts and Trend Analyses, 2017 to 2030
  6.7.1 HOSPITALS & CLINICS
    6.7.1.1 Hospital & clinics market, 2017 - 2030 (USD Million)
  6.7.2 REPRODUCTIVE CARE CENTERS
    6.7.2.1 Reproductive care centers market, 2017 - 2030 (USD Million)
  6.7.3 OTHERS
    6.7.3.1 Others market, 2017 - 2030 (USD Million)

CHAPTER 8 THERAPEUTIC BEDS MARKET: REGIONAL MARKET ANALYSIS, BY PRODUCT, BY APPLICATION, BY END-USE, 2017 - 2030 (USD MILLION)

7.1 Therapeutic Beds: Market Share Analysis, 2021
7.2 North America
  7.2.1 North America therapeutic beds market, 2017 - 2030 (USD Million)
  7.2.2 U.S.
    7.2.2.1 U.S. therapeutic beds market, 2017 - 2030 (USD Million)
  7.2.3 Canada
    7.2.3.1 Canada therapeutic beds market, 2017 - 2030 (USD Million)
7.3 Europe
  7.3.1 Europe therapeutic beds market, 2017 - 2030 (USD Million)
  7.3.2 U.K.
    7.3.2.1 U.K. therapeutic beds market, 2017 - 2030 (USD Million)
  7.3.3 Germany
    7.3.3.1 Germany therapeutic beds market, 2017 - 2030 (USD Million)
  7.3.4 France
    7.3.4.1 France therapeutic beds market, 2017 - 2030 (USD Million)
  7.3.5 Italy
    7.3.5.1 Italy therapeutic beds market, 2017 - 2030 (USD Million)
  7.3.6 Spain
    7.3.6.1 Spain therapeutic beds market, 2017 - 2030 (USD Million)
7.4 Asia Pacific
  7.4.1 Asia Pacific therapeutic beds market, 2017 - 2030 (USD Million)
  7.4.2 Japan
    7.4.2.1 Japan therapeutic beds market, 2017 - 2030 (USD Million)
  7.4.3 China
    7.4.3.1 China therapeutic beds market, 2017 - 2030 (USD Million)
  7.4.4 India
    7.4.4.1 India therapeutic beds market, 2017 - 2030 (USD Million)
  7.4.5 Australia
    7.4.5.1 Australia therapeutic beds market, 2017 - 2030 (USD Million)
  7.4.6 South Korea
    7.4.6.1 South Korea therapeutic beds market, 2017 - 2030 (USD Million)
7.5 Latin America
  7.5.1 Latin America therapeutic beds market, 2017 - 2030 (USD Million)
  7.5.2 Brazil
    7.5.2.1 Brazil therapeutic beds market, 2017 - 2030 (USD Million)
  7.5.3 Mexico
    7.5.3.1 Mexico therapeutic beds market, 2017 - 2030 (USD Million)
  7.5.4 Argentina
    7.5.4.1 Argentina therapeutic beds market, 2017 - 2030 (USD Million)
  7.5.5 Colombia
    7.5.5.1 Colombia therapeutic beds market, 2017 - 2030 (USD Million)
7.6 MEA
  7.6.1 MEA therapeutic beds market, 2017 - 2030 (USD Million)
  7.6.2 South Africa
    7.6.2.1 South Africa therapeutic beds market, 2017 - 2030 (USD Million)
  7.6.3 Saudi Arabia
    7.6.3.1 Saudi Arabia therapeutic beds market, 2017 - 2030 (USD Million)
  7.6.4 UAE
    7.6.4.1 UAE therapeutic beds market, 2017 - 2030 (USD Million)

CHAPTER 9 COMPANY PROFILES

8.1 Company Profiles
  8.1.1 HILL-ROM SERVICES, INC. (BAXTER)
    8.1.1.1 Company overview
    8.1.1.2 Financial performance
    8.1.1.3 Product benchmarking
  8.1.2 ARJOHUNTLEIGH (ARJO)
    8.1.2.1 Company overview
    8.1.2.2 Financial performance
    8.1.2.3 Product benchmarking
  8.1.3 Invacare Corporation
    8.1.3.1 Company overview
    8.1.3.2 Financial performance
    8.1.3.3 Product benchmarking
  8.1.4 STRYKER
    8.1.4.1 Company overview
    8.1.4.2 Product benchmarking
  8.1.5 MEDLINE INDUSTRIES, INC.
    8.1.5.1 Company overview
    8.1.5.2 Financial performance
    8.1.5.3 Product benchmarking
  8.1.6 GF HEALTH PRODUCTS, INC.
    8.1.6.1 Company overview
    8.1.6.2 Product benchmarking
  8.1.7 HARD MANUFACTURING COMPANY INC
    8.1.7.1 Company overview
    8.1.7.2 Product benchmarking
  8.1.8 BAKARE BEDS LTD
    8.1.8.1 Company overview
    8.1.8.2 Product benchmarking
  8.1.9 AMICO CORPORATION
    8.1.9.1 Company overview
    8.1.9.2 Product benchmarking
  8.1.10 MEDICAL DEPOT.INC. (DRIVE DEVILBISS HEALTHCARE)
    8.1.10.1 Company overview
    8.1.10.2 Product benchmarking
  8.1.11 GENDRON, INC.
    8.1.11.1 Company overview
    8.1.11.2 Product benchmarking

List Of Tables

LIST OF TABLES

Table 1 Total number of hospital beds in different countries in 2021
Table 2 List of secondary sources
Table 3 List of abbreviations
Table 4 Estimated number of new cases in 2020, worldwide, males and females of all ages-
Table 5 Injury hospitalizations by age and gender, Canada, 2019 - 2020
Table 6 Product classification list in the U.S.
Table 7 List of products with their respective class
Table 8 Product classification based on their risk type
Table 9 Product classification based on their risk type and other properties
Table 10 The classification is based on the medical device's intended function
Table 11 The classification is based on the medical device's intended function
Table 12 Estimate of the total number of hospitals along with the total number of hospital admissions in the U.S.
Table 13 Neonatal care resources and hospitalization in hospitals of different regions and levels in China in 2018
Table 14 Estimate of bariatric surgery numbers, 2011 - 2019
Table 15 Number of critical care beds
Table 16 Estimated minimum total need and unmet need for surgery by global burden of disease epidemiological region
Table 17 Total health expenditure per capita by health spending category, Canada, 2019 (dollars)
Table 18 Estimated number of seriously injured road users admitted to hospital in France between 2010 and 2017
Table 19 Distribution of type of injury suffered by patients in India

List Of Figures

LIST OF FIGURES

Fig. 1 Therapeutic bed market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market summary (2021)
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Age standardized hospital admission rate per 100,000 population, 2018
Fig. 12 Annual health spending growth for selected categories, 2019 and 2020
Fig. 13 Health expenditure as a percentage of GDP in 2018 (out-of-pocket and public)
Fig. 14 Rate of hospitalization for COVID-19 with age
Fig. 15 Percentage distribution of population aged 65 years and over, by region: 2015 and 2050
Fig. 16 Market restraint relevance analysis (Current & future impact)
Fig. 17 Public expenditure on health in 2018 or nearest (as % of GDP)
Fig. 18 Market opportunities relevance analysis (Current & future impact)
Fig. 19 Porter’s five forces analysis
Fig. 20 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 21 Total number of hospital beds per 1,000 person during COVID-19
Fig. 22 COVID-19 hospital and ICU occupancy on March 28, 2021, compared with December 26, 2020
Fig. 23 Total health spending in Canada during COVID-19
Fig. 24 Therapeutic bed market: Product movement analysis
Fig. 25 Therapeutic bed market product outlook: Key takeaways
Fig. 26 Clinical beds market, 2017 - 2030 (USD Million)
Fig. 27 Regular beds market, 2017 - 2030 (USD Million)
Fig. 28 ICU bed capacity (per 100,000) by population
Fig. 29 The occupancy rate of ICU inpatient adult beds in 2022 for all causes
Fig. 30 Estimated number of ICU beds in India
Fig. 31 ICU beds market, 2017 - 2030 (USD Million)
Fig. 32 Pediatric beds market, 2017 - 2030 (USD Million)
Fig. 33 Birthing beds market, 2017 - 2030 (USD Million)
Fig. 34 Bariatric beds market, 2017 - 2030 (USD Million)
Fig. 35 Low air loss beds market, 2017 - 2030 (USD Million)
Fig. 36 Others market, 2017 - 2030 (USD Million)
Fig. 37 Household beds market, 2017 - 2030 (USD Million)
Fig. 38 Accessories market, 2017 - 2030 (USD Million)
Fig. 39 Therapeutic bed market: Application movement analysis
Fig. 40 Therapeutic bed market application outlook: Key takeaways
Fig. 41 Total number of acute care hospital beds per 1,000 person during COVID-19
Fig. 42 Acute care beds market, 2017 - 2030 (USD Million)
Fig. 43 The underlying cause of the differences in the dominant cardiovascular disease subtypes in Asian
Fig. 44 Critical care beds market, 2017 - 2030 (USD Million)
Fig. 45 Distribution of spending on services by types of services
Fig. 46 Proportion of older adults receiving long-term care at home in OECD countries in 2018
Fig. 47 Long-term beds market, 2017 - 2030 (USD Million)
Fig. 48 Therapeutic bed market: End-use movement analysis
Fig. 49 Therapeutic bed market end-use outlook: Key takeaways
Fig. 50 Hospital & Clinics’s & clinics market, 2017 - 2030 (USD Million)
Fig. 51 Reproductive care centers market, 2017 - 2030 (USD Million)
Fig. 52 Other market, 2017 - 2030 (USD Million)
Fig. 53 Regional outlook, 2021 & 2030
Fig. 54 Regional market place: Key takeaways
Fig. 55 Chronic disease statistics
Fig. 56 North America therapeutic bed market, 2017 - 2030 (USD million)
Fig. 57 Type of admission, 2018
Fig. 58 U.S. therapeutic bed market, 2017 - 2030 (USD Million)
Fig. 59 Total health expenditure
Fig. 60 Canada therapeutic bed market, 2017 - 2030 (USD Million)
Fig. 61 Percentage of hospital admissions in selected European Union countries
Fig. 62 Europe therapeutic bed market, 2017 - 2030 (USD Million)
Fig. 63 U.K. therapeutic bed market, 2017 - 2030 (USD Million)
Fig. 64 Germany therapeutic bed market, 2017 - 2030 (USD Million)
Fig. 65 France therapeutic bed market, 2017 - 2030 (USD Million)
Fig. 66 Italy therapeutic bed market, 2017 - 2030 (USD Million)
Fig. 67 Spain therapeutic bed market, 2017 - 2030 (USD Million)
Fig. 68 Demographic trend in China, India and Japan (in billions)
Fig. 69 Asia Pacific therapeutic bed market, 2017 - 2030 (USD Million)
Fig. 70 Japan therapeutic bed market, 2017 - 2030 (USD Million)
Fig. 71 Percentage share in private hospitals by bed capacity in China
Fig. 72 Percentage share in public hospitals by bed capacity in China
Fig. 73 China (Mainland) therapeutic bed market, 2017 - 2030 (USD Million)
Fig. 74 India therapeutic bed market, 2017 - 2030 (USD Million)
Fig. 75 Hospital & Clinicsizations by urgency of admission and same-day/overnight status, public and private hospitals 2017-18
Fig. 76 Australia therapeutic bed market, 2017 - 2030 (USD Million)
Fig. 77 Per capita and % of GDP
Fig. 78 South Korea therapeutic bed market, 2017 - 2030 (USD Million)
Fig. 79 Latin America therapeutic bed market, 2017 - 2030 (USD Million)
Fig. 80 Brazil therapeutic bed market, 2017 - 2030 (USD Million)
Fig. 81 Noncommunicable diseases (NCD) proportional mortality
Fig. 82 Mexico therapeutic bed market, 2017 - 2030 (USD Million)
Fig. 83 Argentina therapeutic bed market, 2017 - 2030 (USD Million)
Fig. 84 Colombia therapeutic bed market, 2017 - 2030 (USD Million)
Fig. 85 MEA therapeutic bed market, 2017 - 2030 (USD Million)
Fig. 86 South Africa therapeutic bed market, 2017 - 2030 (USD Million)
Fig. 87 Saudi Arabia therapeutic bed market, 2017 - 2030 (USD Million)
Fig. 88 UAE therapeutic bed market, 2017 - 2030 (USD Million)